Michiaki Kohno
Ube, 7558505, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure.
Journal: Journal of molecular and cellular cardiology
Published: January 16, 2023
Enhancing calmodulin binding to cardiac ryanodine receptor completely inhibits pressure-overload induced hypertrophic signaling.
Journal: Communications biology
Published: March 11, 2020
Detection of Active Inflammation Status Around Ventricular Aneurysms in Patients With Cardiac Sarcoidosis.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: October 22, 2019
Dantrolene prevents ventricular tachycardia by stabilizing the ryanodine receptor in pressure- overload induced failing hearts.
Journal: Biochemical and biophysical research communications
Published: September 20, 2019
Cuff-Based Oscillometric Measurements of Central Hemodynamics: Factors Influencing Central Augmentation Pressure in Normotensive Japanese Individuals.
Journal: Pulse (Basel, Switzerland)
Published: August 29, 2018
Addition of a β1-Blocker to Milrinone Treatment Improves Cardiac Function in Patients with Acute Heart Failure and Rapid Atrial Fibrillation.
Journal: Cardiology
Published: June 20, 2018
Urinary 8-Hydroxy-2'-Deoxyguanosine as a Myocardial Oxidative Stress Marker Is Associated With Ventricular Tachycardia in Patients With Active Cardiac Sarcoidosis.
Journal: Circulation. Cardiovascular imaging
Published: June 05, 2017
Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes.
Journal: American journal of physiology. Endocrinology and metabolism
Published: October 19, 2015
ERK signaling promotes cell motility by inducing the localization of myosin 1E to lamellipodial tips.
Journal: The Journal of cell biology
Published: March 26, 2015
KGFR as a possible therapeutic target in middle ear cholesteatoma.
Journal: Acta oto-laryngologica
Published: October 16, 2014
Blockade of the ERK pathway enhances the therapeutic efficacy of the histone deacetylase inhibitor MS-275 in human tumor xenograft models.
Journal: Biochemical and biophysical research communications
Published: February 28, 2013
Last Updated: 09/26/2026